Pharmacological therapy of vascular malformations of the gastrointestinal tract

Canadian Journal of Gastroenterology

Volumn 20, Issue 3, 2006, Pages 171-178

  Szilagyi, Andrew ^a   Ghali, Maged P ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Gastrointestinal; Malformations; Pharmacological; Therapy; Vascular

Indexed keywords

ACETYLSALICYLIC ACID; AMINOCAPROIC ACID; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; DANAZOL; DESMOPRESSIN; ESTROGEN; OCTREOTIDE; PREDNISONE; PROGESTERONE; SOMATOSTATIN DERIVATIVE; TRANEXAMIC ACID; TUMOR NECROSIS FACTOR ANTIBODY;

ABDOMINAL PAIN; ADJUVANT THERAPY; ANGIODYSPLASIA; ARTERIOVENOUS MALFORMATION; BLOOD CLOTTING; BODY WEIGHT DISORDER; BREAKTHROUGH BLEEDING; BREAST DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DIARRHEA; DISEASE EXACERBATION; DIZZINESS; DRUG ERUPTION; ENDOMETRIUM CANCER; ENDOSCOPIC THERAPY; EVIDENCE BASED MEDICINE; FATIGUE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HEMOSTASIS; HUMAN; HYPOTENSION; INJECTION PAIN; IRON DEFICIENCY ANEMIA; KIDNEY DYSFUNCTION; LIBIDO DISORDER; MASTALGIA; MEDICAL LITERATURE; MUSCLE CRAMP; NAUSEA; OUTCOME ASSESSMENT; PERIPHERAL BLOOD VESSEL MALFORMATION; PERIPHERAL NEUROPATHY; POSTMENOPAUSE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; REVIEW; TASTE DISORDER; THROMBOEMBOLISM; THROMBOSIS; WEAKNESS; WEIGHT GAIN;

EID: 33645908821     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2006/859435     Document Type: Review

References (98)

1. Zuckerman GR, Prakash C, Askin MP, Lewis BS. AGA technical review on the evaluation and management of occult and obscure gastrointestinal bleeding. Gastroenterology 2000;118:201-21.
2. Foutch PG, Rex DK, Lieberman DA. Prevalence and natural history of colonic angiodysplasia among healthy asymptomatic people. Am J Gastroenterol 1995;90:564-7.
3. Buchi KN. Vascular malformations of the gastrointestinal tract. Surg Clin North Am 1992;72:559-70.
4. Korzenik JR. Hereditary hemorrhagic telangiectasia and other intestinal vascular anomalies. Gastroenterologist 1996;4:203-10.
5. Foutch PG. Angiodysplasia of the gastrointestinal tract. Am J Gastroenterol 1993;88:807-18.
6. Vakil N, Huilgol V, Khan I. Effect of push enteroscopy on transfusion requirements and quality of life in patients with unexplained gastrointestinal bleeding. Am J Gastroenterol 1997;92:425-8.
7. Pennazio M, Santucci R, Rondonotti E, et al. Outcome of patients with obscure gastrointestinal bleeding after capsule endoscopy: Report of 100 consecutive cases. Gastroenterology 2004;126:643-53.
8. Van Cutsem E, Piessevaux H. Pharmacologic therapy of arteriovenous malformations. Gastrointest Endosc Clin N Am 1996;6:819-32.
9. Sebastian S, O'Morain CA, Buckley MJ. Review article: Current therapeutic options for gastric antral vascular ectasia. Aliment Pharmacol Ther 2003;18:157-65.
10. Lewis BS. Medical and hormonal therapy in occult gastrointestinal bleeding. Semin Gastrointest Dis 1999;10:71-7.
11. Boley SJ, Sammartano R, Adams A, DiBiase A, Kleinhaus S, Sprayregen S. On the nature and etiology of vascular ectasias of the colon. Degenerative lesions of aging. Gastroenterology 1977;72:650-60.
12. Junquera F, Saperas E, de Torres I, Vidal MT, Malagelada JR. Increased expression of angiogenic factors in human colonic angiodysplasia. Am J Gastroenterol 1999;94:1070-6.
13. Harris AL. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002;1:38-47.
14. Boley SJ, Brandt LJ. Vascular ectasias of the colon - 1986. Dig Dis Sci 1986;31(9 Suppl):26S-42S.
15. Warkentin TE, Moore JC, Anand SS, Lonn EM, Morgan DG. Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome. Transfus Med Rev 2003;17:272-86.
16. Vincentelli A, Susen S, Le Tourneau T, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003;349:343-9.
17. Kwaan HC, Silverman S. Fibrinolytic activity in lesions of hereditary hemorrhagic telangiectasia. Arch Dermatol 1973;107:571-3.
18. Cirulli A, Liso A, D'Ovidio F, et al. Vascular endothelial growth factor serum levels are elevated in patients with hereditary hemorrhagic telangiectasia. Acta Haematol 2003;110:29-32.
19. Greenwald DA, Brandt LJ. Vascular lesions of the gastrointestinal tract. In: Feldman M, Friedman LS, Sleisinger MH, eds. Sleisinger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management, 7th edn. Philadelphia: Saunders, 2002:2341-55.
20. Richter JM, Christensen MR, Colditz GA, Nishioka NS. Angiodysplasia. Natural history and efficacy of therapeutic interventions. Dig Dis Sci 1989;34:1542-6.
21. Lewis BS, Salomon P, Rivera-MacMurray S, Kornbluth AA, Wenger J, Waye D. Does hormonal therapy have any benefit for bleeding angiodysplasia? J Clin Gastroenterol 1992;15:99-103.
22. Junquera F, Feu F, Papo M, et al. A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia. Gastroenterology 2001;121:1073-9.
23. Howard OM, Buchanan JD, Hunt RH. Angiodysplasia of the colon. Experience of 26 cases. Lancet 1982;2:16-9.
24. Bown SG, Swain CF, Storey DW, et al. Endoscopic laser treatment of vascular anomalies of the upper gastrointestinal tract. Gut 1985;26:1338-48.
25. Potamiano S, Carter CR, Anderson JR. Endoscopic laser treatment of diffuse gastric antral vascular ectasia. Gut 1994;35:461-3.
26. Rutgeerts P, Van Gompel F, Geboes K, Vantrappen G, Broeckaert L, Coremans G. Long term results of treatment of vascular malformations of the gastrointestinal tract by neodymium Yag laser photocoagulation. Gut 1985;26:586-93.
27. Cello JP, Grendell JH. Endoscopic laser treatment for gastrointestinal vascular ectasias. Ann Intern Med 1986;104:352-4.
28. Gostout CJ, Bowyer BA, Ahlquist DA, Viggiano TR, Balm RK. Mucosal vascular malformations of the gastrointestinal tract: Clinical observations and results of endoscopic neodymium: Yttrium-aluminum-garnet laser therapy. Mayo Clin Proc 1988;63:993-1003.
29. Roberts PL, Schoetz DJ Jr, Coller JA. Vascular ectasia. Diagnosis and treatment by colonoscopy. Am Surg 1988;54:56-9.
30. Lanthier P, d'Harveng B, Vanheuverzwyn R, et al. Colonic angiodysplasia. Follow-up of patients after endoscopic treatment for bleeding lesions. Dis Colon Rectum 1989;32:296-8.
31. Mathus-Vliegen EM. Laser treatment of intestinal vascular abnormalities. Int J Colorectal Dis 1989;4:20-5.
32. Naveau S, Aubert A, Poynard T, Chaput JC. Long-term results of treatment of vascular malformations of the gastrointestinal tract by neodymium Yag laser photocoagulation. Dig Dis Sci 1990;35:821-6.
33. Sargeant IR, Loizou LA, Rampton D, Tulloch M, Bown SG. Laser ablation of upper gastrointestinal vascular ectasias: Long term results. Gut 1993;34:470-5.
34. Gupta N, Longo WE, Vernava AM 3rd. Angiodysplasia of the lower gastrointestinal tract: An entity readily diagnosed by colonoscopy and primarily managed nonoperatively. Dis Colon Rectum 1995;38:979-82.
35. Fogel R, Valdivia EA. Bleeding angiodysplasia of the colon. Curr Treat Options Gastroenterol 2002;5:225-30.
36. Richardson JD. Vascular lesions of the intestines. Am J Surg 1991;161:284-93.
37. Szold A, Katz LB, Lewis BS. Surgical approach to occult gastrointestinal bleeding. Am J Surg 1992;163:90-3.
38. Lewis MP, Khoo DE, Spencer J. Value of laparotomy in the diagnosis of obscure gastrointestinal haemorrhage. Gut 1995;37:187-90.
39. Douard R, Wind P, Panis Y, et al. Intraoperative enteroscopy for diagnosis and management of unexplained gastrointestinal bleeding. Am J Surg 2000;180:181-4.
40. Longacre AV, Gross CF, Gallitelti M, Henderson KJ, White RI Jr, Proctor DD. Diagnosis and management of gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastroenterol 2003;98:59-65.
41. Koch HJ, Escher GC, Lewis JS. Hormonal management of hereditary hemorrhagic telangiectasia. J Am Med Assoc 1952;149:1376-80.
42. Harrison DF. Use of estrogen in treatment of familial hemorrhagic telangiectasia. Laryngoscope 1982;92:314-20.
43. Vase P. Estrogen treatment of hereditary hemorrhagic telangiectasia. A double-blind controlled clinical trial. Acta Med Scand 1981;209:393-6.
44. Tran A, Villeneuve JP, Bilodeau M, et al. Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: An open pilot study. Am J Gastroenterol 1999;94:2909-11.
45. Moss SF, Ghosh P, Thomas DM, Jackson JE, Calam J. Gastric antral vascular ectasia: Maintenance treatment with oestrogen-progesterone. Gut 1992;33:715-7.
46. Manning RJ. Estrogen/progesterone treatment of diffuse antral vascular ectasia. Am J Gastroenterol 1995;90:154-6.
47. Hermans C, Goffin E, Horsmans Y, Laterre E, Van Ypersele de Strihou C. Watermelon stomach. An unusual cause of recurrent upper GI tract bleeding in the uraemic patient: Efficient treatment with oestrogen-progesterone therapy. Nephrol Dial Transplant 1996;11:871-4.
48. Granieri R, Mazzulla JP, Yarborough GW. Estrogen-progesterone therapy for recurrent gastrointestinal bleeding secondary to gastrointestinal angiodysplasia. Am J Gastroenterol 1988;83:556-8.
49. Bronner MH, Pate MB, Cunningham JT, Marsh WH. Estrogen-progesterone therapy for bleeding gastrointestinal telangiectasias in chronic renal failure. An uncontrolled trial. Ann Intern Med 1986;105:371-4.
50. Moshkowitz M, Arber N, Amir N, Gilat T. Success of estrogen-progesterone therapy in long-standing bleeding gastrointestinal angiodysplasia. Report of a case. Dis Colon Rectum 1993;36:194-6.
51. Bellucci S, Zini JM, Bitoun P, et al. Diffuse severe digestive angiodysplasia in Bernard-Soulier syndrome. Improvement of bleeding by oestroprogestative therapy. Thromb Haemost 1995;74:1610-2.
52. Yuksel O, Koklu S, Ucar E, Sasmaz N, Sahin B. Severe recurrent gastrointestinal bleeding due to angiodysplasia in a Bernard-Soulier patient: An onerous medical concomitance. Dig Dis Sci 2004;49:885-7.
53. Van Cutsem E, Rutgeerts P, Geboes K, Van Gompel F, Vantrappen G. Estrogen-progesterone treatment of Osler-Weber-Rendu disease. J Clin Gastroenterol 1988;10:676-9.
54. McGee R. Estrogen-progestogen therapy for gastrointestinal bleeding in hereditary hemorrhagic telangiectasia. South Med J 1979;72:1503.
55. Barkin JS, Ross BS. Medical therapy for chronic gastrointestinal bleeding of obscure origin. Am J Gastroenterol 1998;93:1250-4.
56. Van Cutsem E, Rutgeerts P, Vantrappen G. Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone. Lancet 1990;335:953-5.
57. Van Cutsem E, Rutgeerts P, Vantrappen G. Long-term effect of hormonal therapy for bleeding gastrointestinal vascular malformations. Eu J Gastroenterol Hepatol 1993;5:439-43.
58. Madanick RD, Barkin JS. Hormonal therapy in angiodysplasia: Should we completely abandon its use? Gastroenterology 2002;123:2156-7.
59. Tulassay Z. Somatostatin and the gastrointestinal tract. Scand J Gastroenterol Suppl 1998;228:115-21.
60. Scarpignato C, Pelosini I. Somatostatin for upper gastrointestinal hemorrhage and pancreatic surgery. A review of its pharmacology and safety. Digestion 1999;60(Suppl 3):1-16.
61. Kubba AK, Dallal H, Haydon GH, Hayes PC, Palmer KR. The effect of octreotide on gastroduodenal blood flow measured by laser Doppler flowmetry in rabbits and man. Am J Gastroenterol 1999;94:1077-82.
62. Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ. Octreotide. N Engl J Med 1996;334:246-54.
63. Barrie R, Woltering EA, Hajarizadeh H, Mueller C, Ure T, Fletcher WS. Inhibition of angiogenesis by somatostatin and somatostatin-like compounds is structurally dependent. J Surg Res 1993;55:446-50.
64. Pennazio M, Arrigoni A, Risio M, Spandre M, Rossini FP. Clinical evaluation of push-type enteroscopy. Endoscopy 1995;27:164-70.
65. Torsoli A, Annibale B, Viscardi A, Delle Fave G. Treatment of bleeding due to diffuse angiodysplasia of the small intestine with somatostatin analogue. Eur J Gastroenterol Hepatol 1991;3:785-7.
66. Rossini FP, Arrigoni A, Pennazio M. Octreotide in the treatment of bleeding due to angiodysplasia of the small intestine. Am J Gastroenterol 1993;88:1424-7.
67. Andersen MR, Aaseby J. Somatostatin in the treatment of gastrointestinal bleeding caused by angiodysplasia. Scand J Gastroenterol 1996;31:1037-9.
68. Barbara G, De Giorgio R, Salvioli B, Stanghellini V, Corinaldesi R. Unsuccessful octreotide treatment of the watermelon stomach. J Clin Gastroenterol 1998;26:345-6.
69. Bowers M, McNulty O, Mayne E. Octreotide in the treatment of gastrointestinal bleeding caused by angiodysplasia in two patients with von Willebrand's disease. Br J Haematol 2000;108:524-7.
70. Orsi P, Guatti-Zuliani C, Okolicsanyi L. Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract. Dig Liver Dis 2001;33:330-4.
71. Nordquist LT, Wallach PM. Octreotide for gastrointestinal bleeding of obscure origin in an anticoagulated patient. Dig Dis Sci 2002;47:1514-5.
72. Coppola A, De Stefano V, Tufano A, et al. Long-Lasting intestinal bleeding in an old patient with multiple mucosal vascular abnormalities and Glanzmann's thrombasthenia: 3-year pharmacological management. J Intern Med 2002;252:271-5.
73. Blich M, Fruchter O, Edelstein S, Edoute Y. Somatostatin therapy ameliorates chronic and refractory gastrointestinal bleeding caused by diffuse angiodysplasia in a patient on anticoagulation therapy. Scand J Gastroenterol 2003;38:801-3.
74. Gonzalez D, Elizondo BJ, Haslag S, et al. Chronic subcutaneous octreotide decreases gastrointestinal blood loss on blue rubber-bleb nevus syndrome. J Pediatr Gastroenterol Nutr 2001;33:183-8.
75. Zellos A, Schwarz KB. Efficacy of octreotide in children with chronic gastrointestinal bleeding. J Pediatr Gastroenterol Nutr 2000;30:442-6.
76. Pennazio et al. Diagnostic yield and therapeutic implications of push enteroscopy in patients with obscure gastrointestinal bleeding. Am J Gastroenterol 1995;90:1632. (Abst)
77. Nardone G, Rocco A, Balzano T, Budillon G. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther 1999;13:1429-36.
78. Sorrentino P, Tarantino G, Conca P, Perrella A. Should octreotide be used cautiously in liver cirrhosis with concomitant congestive heart failure correlated to coronary artery disease? Dig Dis Sci 2003;48:1919.
79. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004;350:1013-22.
80. Calam J, Walker RJ. Antral vascular lesion, achlorhydria, and chronic gastrointestinal blood loss: Response to steroids. Dig Dis Sci 1980;25:236-9.
81. Jabbari M, Cherry R, Lough JO, Daly DS, Kinnear DG, Goresky CA. Gastric antral vascular ectasia: The watermelon stomach. Gastroenterology 1984;87:1165-70.
82. Lorenzi AR, Johnson AH, Davies G, Gough A. Gastric antral vascular ectasia in systemic sclerosis: Complete resolution with methylprednisolone and cyclophosphamide. Ann Rheum Dis 2001;60:796-8.
83. Fishman SJ, Burrows PE, Leichtner AM, Mulliken JB. Gastrointestinal manifestations of vascular anomalies in childhood: Varied etiologies require multiple therapeutic modalities. J Pediatr Surg 1998;33:1163-7.
84. Haq AU, Glass J, Netchvolodoff CV, Bowen LM. Hereditary hemorrhagic telangiectasia and danazol. Ann Intern Med 1988;109:171.
85. Korzenik et al. Danazol in the treatment of GI hemorrhage secondary to hereditary hemorrhagic telangiectasia. Gastroenterology 1995;108:A297. (Abst)
86. Sabba C, Gallitelli M, Palasciano G. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia. N Engl J Med 2001;345:926.
87. Vujkovac B, Lavre J, Sabovic M. Successful treatment of bleeding from colonic angiodysplasias with tranexamic acid in a hemodialysis patient. Am J Kidney Dis 1998;31:536-8.
88. Saba HI, Morelli GA, Logrono LA. Brief report: Treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid. N Engl J Med 1994;330:1789-90.
89. Annichino-Bizzacchi JM, Facchini RM, Torresan MZ, Arruda VR. Hereditary hemorrhagic telangiectasia response to aminocaproic acid treatment. Thromb Res 1999;96:73-6.
90. Quitt M, Froom P, Veisler A, Falber V, Sova J, Aghai E. The effect of desmopressin on massive gastrointestinal bleeding in hereditary telangiectasia unresponsive to treatment with cryoprecipitate. Arch Intern Med 1990;150:1744-6.
91. Athanasoulis CA, Baum S, Rosch J, et al. Mesenteric arterial infusions of vasopressin for hemorrhage from colonic diverticulosis. Am J Surg 1975;129:212-6.
92. Rahmani R, Rozen P, Papo J, Iellin A, Seligsohn U. Association of von Willebrand's disease with plasma cell dyscrasia and gastrointestinal angiodysplasia. Isr J Med Sci 1990;26:504-9.
93. Alhumood SA, Devine DV, Lawson L, Nantel SH, Carter CJ. Idiopathic immune-mediated acquired von Willebrand's disease in a patient with angiodysplasia: Demonstration of an unusual inhibitor causing a functional defect and rapid clearance of von Willebrand factor. Am J Hematol 1999;60:151-7.
94. Perez-Encinas M, Rabunal Martinez MJ, Bello Lopez JL. Is thalidomide effective for the treatment of gastrointestinal bleeding in hereditary hemorrhagic telangiectasia? Haematologica 2002;87:ELT34. (Lett).
95. Shurafa M, Kamboj G. Thalidomide for the treatment of bleeding angiodysplasias. Am J Gastroenterol 2003;98:221-2.
96. Bauditz J, Schachschal G, Wedel S, Lochs H. Thalidomide for treatment of severe intestinal bleeding. Gut 2004;53:609-12.
97. Meijer K, Peters FT, van der Meer J. Recurrent severe bleeding from gastrointestinal angiodysplasia in a patient with von Willebrand's disease, controlled with recombinant factor VIIa. Blood Coagul Fibrinolysis 2001;12:211-3.
98. Zanon E, Vianello F, Casonato A, Girolami A. Early transfusion of factor VIII/von Willebrand factor concentrates seems to be effective in the treatment of gastrointestinal bleeding in patients with von Willebrand type III disease. Haemophilia 2001;7:500-3.